Evidence map›Paper›PMID 38133868›Full record

ArticleBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2024

In vitro assessment of antibacterial and antiviral activity of three copper products after 200 rounds of simulated use.

Marthe K Charles, Teresa C Williams, Davood Nakhaie, Tracey Woznow, Billie Velapatino, Ana C Lorenzo-Leal, Horacio Bach, Elizabeth A Bryce, Edouard Asselin

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. In Vitro Antibacterial Efficacy of a New TiONanomaterials (Basel, Switzerland) · 2025
    Article
  3. Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marthe K CharlesDivision of Medical Microbiology and Infection Prevention and Control, Vancouver Coastal Health, Vancouver, BC, Canada. marthe.charles@vch.ca.
Teresa C WilliamsDivision of Medical Microbiology and Infection Prevention and Control, Vancouver Coastal Health, Vancouver, BC, Canada.
Davood NakhaieDepartment of Materials Engineering, University of British Columbia, Vancouver, BC, Canada.
Tracey WoznowDivision of Medical Microbiology and Infection Prevention and Control, Vancouver Coastal Health, Vancouver, BC, Canada.
Billie VelapatinoDivision of Medical Microbiology and Infection Prevention and Control, Vancouver Coastal Health, Vancouver, BC, Canada.
Ana C Lorenzo-LealDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Horacio BachDivision of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Elizabeth A BryceDivision of Medical Microbiology and Infection Prevention and Control, Vancouver Coastal Health, Vancouver, BC, Canada.
Edouard AsselinDepartment of Materials Engineering, University of British Columbia, Vancouver, BC, Canada.
University of British Columbia · CAVancouver Coastal Health · CAMartec (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper has well-documented antibacterial effects but few have evaluated it after prolonged use and against bacteria and viruses. Coupons from three copper formulations (solid, thermal coating, and decal applications) and carbon steel controls were subjected to 200 rounds simulated cleaning using a Wiperator™ and either an accelerated hydrogen peroxide, quaternary ammonium, or artificial sweat products. Antibacterial activity against S. aureus and P. aeruginosa was then evaluated using a modified Environmental Protection Agency protocol. Antiviral activity against coronavirus (229E) and norovirus (MNV-1) surrogates was assessed using the TCID

Indexed as

Anti-Bacterial AgentsAntiviral AgentsCopperStaphylococcus aureusCoronavirus 229E, HumanDisinfectantsHumansHydrogen PeroxideMicrobial Sensitivity TestsNorovirusPseudomonas aeruginosaAnti-Bacterial AgentsAntiviral AgentsCopperDisinfectantsHydrogen PeroxideAntimicrobial activityBacterial pathogensCopperCoronavirusDisinfectantNorovirusSelf-sanitizing surfaces

Identifiers

PMID38133868
PMCPMC11255078
OpenAlexW4390112236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.